Summary
The present study examines the possibility that lesions induced by intrastriatal injections of endothelin-1 (ET-1, 0.43 nmol/0.5 µl) are ischemic in nature due to a vasoconstriction of the cerebral microvessels. In time course and dose-response experiments with ET-1 and in comparisons with ET-3, the volume of the lesions has been determined based mainly on the disappearance of striatal nerve cells, using a computer assisted morphometrical analysis. The blood flow in the neostriatum close to the site of injection of ET-1 was determined acutely by Laser-Doppler flowmetry. The acute metabolic effects of ET-1 were also studied on striatal superfusate levels of lactate, pyruvate, dopamine and its metabolites DOPAC (3,4-dihydroxyphenylacetic acid) and homovanilic acid (HVA) using an instrastriatal microdialysis probe. Dose related striatal lesions were observed with ET-1 (0.043–0.43 nmol) with a peak lesion volume after 24–48 h and the possible existence of a penumbra area. ET-3 showed a reduced potency to produce striatal lesions compared to ET-1. The lesions induced by ET-1 were prevented by coinjection with dihydralazine, a vasodilator drug. Acutely ET-1 (0.43 nmol/0.5 µl) produced a prolonged reduction of the cerebral blood flow down to 40% of control values and temporary increases of striatal lactate and DA efflux, the latter change being very marked. Also a significant reduction of DOPAC and HVA was observed. These neurochemical changes were all prevented by treatment with dihydralazine. These results indicate that ET-1 injected in the neostriatum may produce lesions by causing local ischemia, related to its vasoconstrictor activity and possibly also to an activation of ET-1 receptors in the astroglial-endothelial complex. Based on the present results it seems possible that ET-1 may participate in the multifactorial pathogenesis of cerebral ischemia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agnati LF, Fuxe K, Zoli M, Zini I, Härfstrand A, Toffano G, Goldstein M (1988) Morphometrical and microdensitometrical studies on phenylethanolamine-N-methyltransferase- and neuropeptide Y-immunoreactive neurons in the rostral medulla oblongata of the adult and old male rat. Neuroscience 26:461–478
Bolander HG, Persson L, Hillered L, d'Argy R, Ponten U, Olsson Y (1989) Regional cerebral blood flow and histopathologic changes after cerebral artery occlusion in rats. Stroke 20:930–937
Cintra A, Fuxe K, Änggård E, Tinner B, Staines W, Agnati LF (1989) Increased endothelin-like immunoreactivity in ibotenic acid-lesioned hippocampal formation of the rat brain. Acta Physiol Scand 137:557–558
Fuxe K, Cintra A, Andbjer B, Änggård E, Goldstein M, Agnati LF (1989a) Centrally administered endothelin-1 produces lesions in the brain of the male rat. Acta Physiol Scand 137:155–156
Fuxe K, Cintra A, Änggård E, Tinner B, Staines W, Agnati LF, Galton S, Vane JR (1989b) Increased formation of endothelin-like immunoreactivity in activated astroglia and its relation to125I-endothelin-1 binding sites in the rat brain. Neuroscience Abstr 15:126
Fuxe K, Änggård E, Lundgren K, Cintra A, Agnati LF, Galton S, Vane J (1989c) Localization of125I-endothelin-1 and125I-endothelin-3 binding sites in the rat brain. Acta Physiol Scand 137:563–564
Fuxe K, Tinner B, Staines W, Hemsén A, Hersh L, Lundberg JM (1991a) Demonstration and nature of endothelin-3 like immunoreactivity in somatostatin and choline acetyltransferase immunoreactive nerve cells of the neostriatum of the rat. Neurosci Lett 123:107–111
Fuxe K, Kurosawa M, Cintra A, Goiny M, Hallström Å, Rosén L, Ungerstedt U, Agnati LF (1991b) Endothelin-1 induced lesions in the brain as a new model of focal ischemia. In: Conn PM (ed) Methods in Neurosciences, Vol. 7: Transplantations, Lesions and Surgical Techniques, Academic Press Inc, Orlando Florida (in press)
Giaid A, Gibson SJ, Ibrahim NBN, Legon S, Bloom SR, Yanagisawa M, Masaki T, Varndell IM, Polak JM (1989) Endothelin-1, an endothelin-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci USA, 86:7634–7638
Hallström Å, Carlsson A, Hillered L, Ungerstedt U (1989) Simultaneous determination of lactate, pyruvate, and ascorbate in microdialysis samples from rat brain, blood, fat, and muscle using high-performance liquid chromatography. J Pharmacol Methods 22:113–124
Hollander M, Wolfe DA (1973) Nonparametrical statistical methods. Wiley, New York
Hurd YL, Ungerstedt U (1989) In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudateputamen. Eur J Pharmacol 166:251–260
Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologicaly distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863–2867
Jones CR, Hiley CR, Pelton JT, Mohr M (1989) Autoradiographic visualization of the binding sites for125I-endothelin in rat and human brain. Neurosci Lett 97:276–279
Kataoka Y, Koizumi S, Kumakura K, Kurihara M, Niwa M, Ueki S (1989) Endothelin-triggered brain damage under hpoglycemia evidenced by real-time monitoring of dopamine release from rat striatal slices. Neurosci Lett 107:75–80
Koseki C, Imai M, Hirata Y, Yanagisawa M, Masaki T (1989) Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide? Am J Physiol 256 (4 Pt 2):R858–866
Lin WW, Lee CY, Chuang DM (1990) Comparative studies of phosphoinositide hydrolysis induced by endothelin-related peptides in cultured cerebellar astroctes C6-glioma and cerebellar granular cells. Biochem Biophys Res Comm 168:512–519
MacCumber MW, Ross CA, Glaser BM, Snyder SH (1989) Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 86:7285–7289
MacCumber MW, Ross CA, Snyder SH (1990) Endothelin in brain: Receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci USA 87:2359–2363
Marsault R, Vigne P, Breittmayer JP, Frelin (1989) Astrocytes are target cells for endothelins and sarafotoxin. J Neurochem 54:2142–2144
Matsumoto H, Suzuki N, Onda H, Fujino M (1989) Abudance of endothelin-3 in rat intestine, pituitary gland and brain. Biochem Biophys Res Comm 164:74–80
Nickerson M (1974) Antihypertensive agents and the drug therapy of hypertension. In: Goodman, LS, Gilman A (eds) The pharmacological basis of therapeutics 4 edn. The MacMillan Co, London, pp 728–734
Nunez DJ, Brown MJ, Davenport AP, Neylon CB, Schofield JP, Wyse RK (1990) Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest 85:1537–1541
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New York
Shigeno T, Mima T, Takakura K, Yanagisawa M, Saito A, Goto K, Masaki T (1989) Endothelin-1 acts in cerebral arteries from the adventitial but not from the luminal side. J Cardiovasc Pharmacol 13 Suppl 5:S162–165
Siejö BK, Bengtsson F (1988) Calcium, calcium antagonists, and ischemic cell death in the brain. In: Krieglstein J (ed) Pharmacology of the cerebral ischemia 1988. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 23–28
Shinmi O, Kimura S, Sawamura T, Sugita Y, Yoshizawa T, Uchiyama Y, Yanagisawa M, Goto K, Masaki T, Kanazawa I (1989) Endothelin-3 is a novel neuropeptide: isolation and sequence determination of endothelin-1 and endothelin-3 in porcine brain. Biochem Biophys Res Comm 164:587–593
Skarphedinsson JO, Haårding H, Thorén P (1988) Repeated measurements of cerebral blood flow in rats. Comparisons between the hydrogen clearance method and Laser Doppler flowmetry. Acta Physiol Scand 134:133–142
Supattapone S, Simpson AW, Ashle CC (1989) Free calcium rise and mitogenesis in glial cells caused by endothelin. Biochem Biophys Res Comm 165:1115–1122
Symon L (1989) Calcium antagonists in brain ischemia- Experimental observations. In: Hartmann A, Kuschinsky W (eds) Cerebral ischemia and calcium. Springer, Berlin Heidelberg New York pp 131–138
Vigne P, Marsault P, Breittmayer P, Frelin C (1990) Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells. Biochem J 266:415–420
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) Endothelin: a novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415
Yoshimoto S, Ishizaki Y, Kurihara H, Sasaki T, Yoshizumi M, Yanagisawa M, Yazaki Y, Masaki T, Takakura K, Murota S (1990) Cerebral microvessel endothelium is producing endothelin. Brain Res 508:283–285
Yoshishawa T, Shinmi O, Giaid A, Yanagisawa M, Gibson SJ, Kimura S, Uchiyama Y, Polak JM, Masaki T, Kanazawa I (1990) Endothelin: A novel peptide in the posterior pituitary system. Science 247:462–464
Zini I, Grimaldi R, Merlo Pich E, Zoli M, Fuxe K, Agnati LF (1990) Aspects of neural plasticity in the central nervous system-V. Studies on a model of transient forebrain ischemia in male Sprague-Dawley rats. Neurochem Int 16:451–468
Zoli M, Merlo Pich E, Cimino M, Lombardelli G, Peruzzi G, Fuxe K, Agnati LF, Cattabeni F (1990) Morphometrical and microdensitometrical studies on peptide- and tyrosine hydroxylase-like immunoreactivities in the forebrain of rats prenatally exposed to methylazoxymethanol acetate. Develop Brain Res 51:45–61
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fuxe, K., Kurosawa, N., Cintra, A. et al. Involvement of local ischemia in endothelin-1 induced lesions of the neostriatum of the anaesthetized rat. Exp Brain Res 88, 131–139 (1992). https://doi.org/10.1007/BF02259134
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02259134